Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Medical Genetics · Classic Congenital Adrenal Hyperplasia

What Are the Chances of Another Baby With Classic CAH?

At a Glance

For the same two biological parents who each carry a CAH-causing gene change, every pregnancy has a 25% (1-in-4) chance of classic CAH, and previous children do not change the odds. Genetic counseling can help families choose prenatal testing or a newborn monitoring plan.

If you have a child with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, the chance of having another child with the condition is 25% (or 1 in 4) with each future pregnancy, assuming the pregnancy involves the same two biological parents [1][2]. This probability is independent for every pregnancy; having one child with CAH does not reduce or change the risk for the next [2].

Understanding Autosomal Recessive Inheritance

Classic CAH is almost always an autosomal recessive genetic condition caused by changes in the CYP21A2 gene [2][3]. Because humans have two copies of most genes, a child must inherit two disease-causing variants (one from each parent) to be born with classic CAH [1][4].

When both parents are carriers—meaning they each have one normal gene copy and one disease-causing variant, but usually do not have classic CAH themselves—the odds for each pregnancy are:

  • 25% chance the baby will inherit two disease-causing variants and have classic CAH [1].
  • 50% chance the baby will inherit one disease-causing variant and one normal copy, making them a carrier like their parents, but without classic CAH [1].
  • 25% chance the baby will inherit two normal copies, meaning they will not have CAH and will not be a carrier [1].

Because CAH genetics can be complex, meeting with a genetic counselor or a medical geneticist is highly recommended before trying to conceive again [5][4].

A specialist should review the specific CYP21A2 genetic test results of your child with CAH and test both parents to confirm carrier status [4][6]. Identifying your family’s exact disease-causing variants is essential because the CYP21A2 gene region is technically difficult to analyze in a laboratory, often involving gene duplications or complex missing segments [7][8].

Family Planning and Testing Options

Once your family’s specific variants are known, a genetic counselor can help you explore your options. You can choose to conceive naturally or explore assisted reproduction, and testing can be done at different stages.

In-Vitro Fertilization (IVF) with PGT-M

Families may choose IVF combined with Preimplantation Genetic Testing for Monogenic disorders (PGT-M) [5]. This allows a reproductive endocrinologist to test embryos for your family’s specific CAH variants before transferring an embryo to the uterus [9]. While this reduces the chance of having a child with CAH, IVF does not guarantee a pregnancy, not all cycles produce testable or unaffected embryos, and confirmatory testing during pregnancy is still generally recommended [5].

Prenatal Diagnosis During Pregnancy

If you conceive naturally or without PGT-M, testing can be done during pregnancy by a maternal-fetal medicine specialist to see if the fetus has inherited the condition [4]. This requires targeting your family’s specific variants. Options include:

  • Chorionic-Villus Sampling (CVS): A procedure typically performed between 10 to 13 weeks of pregnancy [4].
  • Amniocentesis: A procedure typically performed at or after 15 weeks of pregnancy [4].

Both are invasive procedures with a small risk of complications, which should be discussed with your obstetric team [5].
(Note: You may read about prenatal dexamethasone treatment intended to reduce physical changes in affected female fetuses, but this is considered experimental, not routine care, and should only be discussed with specialists [10][11].)

Postnatal Plan and Newborn Safety

If you choose not to have prenatal testing, it is critical to have a postnatal care plan in place. A baby at risk for classic CAH—particularly the salt-wasting form—can become dangerously ill from an adrenal crisis in the first weeks of life.

Do not rely solely on standard newborn screening. Inform your obstetric and pediatric teams about your family history so they can arrange for targeted hormone testing and pediatric endocrinology monitoring immediately after birth. Seek emergency medical care if a newborn shows warning signs like poor feeding, repeated vomiting, unusual sleepiness, or dehydration.

Common questions in this guide

What is the chance that another baby will have classic CAH?
If the same two biological parents both carry a disease-causing change in CYP21A2, the chance is 25%, or 1 in 4, in every pregnancy. The other possible outcomes are a 50% chance that the baby is a carrier without classic CAH and a 25% chance of inheriting neither disease-causing change.
Does having one child with CAH change the odds for the next pregnancy?
No. If the same two biological parents are carriers, each pregnancy has its own 25% chance, so a previous child with or without classic CAH does not change the odds for the next pregnancy.
What genetic testing should we have before trying for another baby?
A genetic counselor or medical geneticist can review the affected child's CYP21A2 results and arrange testing for both parents. Identifying the family's exact gene changes is important because this gene region can be difficult to analyze and the results guide prenatal testing or IVF with PGT-M.
Can IVF with PGT-M lower the chance of another child having CAH?
Yes. IVF with PGT-M can test embryos for the family's known CAH-related gene changes before an embryo is transferred, which can reduce the chance of transferring an affected embryo. It does not guarantee pregnancy, an unaffected embryo, or a baby without CAH, and confirmatory testing during pregnancy is generally recommended.
When can prenatal testing check whether a baby has classic CAH?
Chorionic villus sampling, or CVS, is typically performed from 10 to 13 weeks of pregnancy, while amniocentesis is usually performed at or after 15 weeks. Both are invasive and have a small risk of complications, so a maternal-fetal medicine specialist and obstetric team should explain the benefits and risks for your situation.
What should we do after birth if we do not have prenatal testing?
Tell the obstetric and pediatric teams before delivery that the baby is at risk for classic CAH, so targeted hormone testing and pediatric endocrinology follow-up can be arranged promptly. Routine newborn screening alone should not replace an individualized plan. Seek emergency care for poor feeding, repeated vomiting, unusual sleepiness, or dehydration because salt-wasting CAH can cause a dangerous adrenal crisis in the first weeks of life.

Get notified when new evidence is published on Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    Has the Era of Individualized Intrauterine Treatment for Congenital Adrenal Hyperplasia Arrived?

    Fu X, Xia Y, Li S, et al.

    Prenatal diagnosis 2025; (45(3)):423-432 doi:10.1002/pd.6747.

    PMID: 39891341
  2. 2

    Genetics of Congenital Adrenal Hyperplasia.

    Hannah-Shmouni F, Chen W, Merke DP

    Endocrinology and metabolism clinics of North America 2017; (46(2)):435-458 doi:10.1016/j.ecl.2017.01.008.

    PMID: 28476231
  3. 3

    Congenital Adrenal Hyperplasia (CAH) due to 21-Hydroxylase Deficiency: A Comprehensive Focus on 233 Pathogenic Variants of CYP21A2 Gene.

    Concolino P, Costella A

    Molecular diagnosis & therapy 2018; (22(3)):261-280 doi:10.1007/s40291-018-0319-y.

    PMID: 29450859
  4. 4

    [Genetic screening and prenatal diagnosis in 18 high-risk families with 21-hydroxylase deficiency].

    Xia Y, Mei S, Hu S, et al.

    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2019; (36(2)):103-107 doi:10.3760/cma.j.issn.1003-9406.2019.02.002.

    PMID: 30703223
  5. 5

    The management of congenital adrenal hyperplasia during preconception, pregnancy, and postpartum.

    Maher JY, Gomez-Lobo V, Merke DP

    Reviews in endocrine & metabolic disorders 2023; (24(1)):71-83 doi:10.1007/s11154-022-09770-5.

    PMID: 36399318
  6. 6

    [Recommendations for the diagnosis and treatment of classic forms of 21-hydroxylase-deficient congenital adrenal hyperplasia].

    Rodríguez A, Ezquieta B, Labarta JI, et al.

    Anales de pediatria (Barcelona, Spain : 2003) 2017; (87(2)):116.e1-116.e10 doi:10.1016/j.anpedi.2016.12.002.

    PMID: 28161392
  7. 7

    EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency.

    Baumgartner-Parzer S, Witsch-Baumgartner M, Hoeppner W

    European journal of human genetics : EJHG 2020; (28(10)):1341-1367 doi:10.1038/s41431-020-0653-5.

    PMID: 32616876
  8. 8

    Molecular Diagnosis of Steroid 21-Hydroxylase Deficiency: A Practical Approach.

    Arriba M, Ezquieta B

    Frontiers in endocrinology 2022; (13()):834549 doi:10.3389/fendo.2022.834549.

    PMID: 35422767
  9. 9

    Prenatal genetic testing and treatment for congenital adrenal hyperplasia.

    Simpson JL, Rechitsky S

    Fertility and sterility 2019; (111(1)):21-23 doi:10.1016/j.fertnstert.2018.11.041.

    PMID: 30611408
  10. 10

    New developments in prenatal diagnosis of congenital adrenal hyperplasia.

    Kazmi D, Bailey J, Yau M, et al.

    The Journal of steroid biochemistry and molecular biology 2017; (165(Pt A)):121-123 doi:10.1016/j.jsbmb.2016.06.016.

    PMID: 27378492
  11. 11

    Congenital Adrenal Hyperplasia: Unresolved Issues.

    Yau M, Khattab A, Poppas D, et al.

    Frontiers of hormone research 2016; (46()):184-95 doi:10.1159/000443919.

    PMID: 27211889

This page explains recurrence risk and testing options for families affected by classic CAH for informational purposes only and does not replace genetic counseling or medical advice. Discuss family planning and newborn care with your healthcare team.